Last reviewed · How we verify

Preoperative Oxycodone

University of Louisville · FDA-approved active Small molecule

Oxycodone is an opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia and sedation for preoperative pain management.

Oxycodone is an opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia and sedation for preoperative pain management. Used for Preoperative analgesia and anxiolysis in surgical patients.

At a glance

Generic namePreoperative Oxycodone
SponsorUniversity of Louisville
Drug classOpioid analgesic
TargetMu opioid receptor (OPRM1)
ModalitySmall molecule
Therapeutic areaPain management / Anesthesia
PhaseFDA-approved

Mechanism of action

Oxycodone activates mu opioid receptors throughout the brain and spinal cord, inhibiting pain signal transmission and producing analgesic and anxiolytic effects. When administered preoperatively, it reduces patient anxiety and provides baseline analgesia prior to surgery, potentially reducing intraoperative anesthetic requirements. The drug crosses the blood-brain barrier readily due to its lipophilic nature, making it effective for systemic pain relief.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results